A minimal IDO1 activity was observed in INCB018424-treated CLL cells, in which the [Kyn]/[Trp] ratio was significantly decreased (0.09 ± 0.054, p = 0.028) (Figure 2C). The gene discussed is IDO1; the disease is B-cell chronic lymphocytic leukemia.